GlaxoSmithKline Posts Stronger Sales In 1Q 2016

GlaxoSmithKline said group sales grew 8 percent to £6.2 billion in the first quarter of 2016, compared with the same quarter in 2015. New product sales reached £821 million during the period, compared with £269 million in the same quarter of 2015. According to the company, core EPS for the quarter was 19.8 pence, an increase of 8 percent. Full-year core EPS percentage growth is expected to be 10–12 percent CER.